Page last updated: 2024-11-05

4-cyanobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Cyanobenzoic acid is a white crystalline solid with the formula C8H5NO2. It is a versatile building block in organic synthesis, often used as an intermediate in the production of pharmaceuticals, agrochemicals, and dyes. Its synthesis typically involves the nitration of toluene followed by hydrolysis and subsequent cyanation. 4-Cyanobenzoic acid is a key component in the synthesis of many compounds, including the anti-inflammatory drug ibuprofen, the antibiotic sulfamethoxazole, and the herbicide dicamba. Its importance stems from its ability to react with a wide range of reagents and to form stable derivatives. The study of 4-cyanobenzoic acid focuses on its reactivity, its role in various synthetic routes, and its potential applications in different fields.'

Cross-References

ID SourceID
PubMed CID12087
CHEMBL ID101772
SCHEMBL ID216706
MeSH IDM0255992

Synonyms (49)

Synonym
AC-2506
CHEMBL101772
4-cyano-benzoic acid
50z9a3423z ,
unii-50z9a3423z
einecs 210-606-9
nsc 6306
p-cyanobenzoic acid
619-65-8
benzoic acid, p-cyano-
p-carboxybenzonitrile
nsc-6306
4-cyanobenzoic acid
benzoic acid, 4-cyano-
nsc6306
AC-907/25014365
inchi=1/c8h5no2/c9-5-6-1-3-7(4-2-6)8(10)11/h1-4h,(h,10,11
4-cyanobenzoic acid, 99%
AKOS000119707
cas-619-65-8
dtxsid9041659 ,
dtxcid7021659
tox21_302120
NCGC00255602-01
terephthalic acid mononitrile
STL164357
4-carboxybenzonitrile
BP-11677
FT-0618298
AM20050235
SCHEMBL216706
4-cyano benzoic acid
cyanobenzoic acid, p-
cyanobenzoic acid, 4-
PS-4038
4-cyanobenzoicacid
W-105067
STR03453
terephthalic mononitrile
mfcd00002528
F2191-0086
4-cyanobenzoic acid (3)
bdbm239164
BCP28910
p-cyanobenzoic acid;benzoic acid, 4-cyano-;p-carboxybenzonitrile
EN300-19927
Q27260843
CK2166
Z104476114
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-carbonic anhydrase 1Mycobacterium tuberculosis H37RvKi2.83670.00483.38419.8400AID1803218
Carbonic anhydrase 2Mycobacterium tuberculosis H37RvKi2.83670.00902.20969.8400AID1803218
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID28692Concentration of the drug in the kidney of rat1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID226477Hammett constant was determined1993Journal of medicinal chemistry, Oct-01, Volume: 36, Issue:20
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
AID226478Hammett constant was evaluated1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID28693Concentration of the drug in the liver of rat1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1803218CA Inhibition Assay from Article 10.3109/14756366.2011.650168: \\Inhibition of the u00DF-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.\\2013Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 28, Issue:2
Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's4 (26.67)18.2507
2000's7 (46.67)29.6817
2010's3 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.01 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index41.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]